The CC-chemokine receptor 5 (CCR5) is a marker of, but not essential for the development of human Th1 cells

被引:20
|
作者
Odum, N
Bregenholt, S
Eriksen, KW
Skov, S
Ryder, LP
Bendtzen, K
Van Neerven, RJJ
Svejgaard, A
Garred, P
机构
[1] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Cell Cybernet Lab, DK-2200 Copenhagen, Denmark
[2] Univ Copenhagen, Panum Inst, Dept Med Anat, DK-2200 Copenhagen, Denmark
[3] Natl Hosp, Tissue Typing Lab, Copenhagen, Denmark
[4] Univ Copenhagen, Natl Hosp, Inst Inflammat Res, Copenhagen, Denmark
[5] ALK ABELLO Grp, Horsholm, Denmark
来源
TISSUE ANTIGENS | 1999年 / 54卷 / 06期
关键词
CCR5; Th1; cytokines;
D O I
10.1034/j.1399-0039.1999.540606.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The CC-chemokine receptor 5 (CCR5) has recently been described as a surface marker of human T cells producing type 1 (Th1) cyto- kines. Here we confirm that CCR5 is expressed on human Th1 but not on Th2 T-cell clones. Using intracellular cytokine staining, we show that alloantigen specific CD4(+) T-cell lines derived from a CCR5-deficient. individual (Delta 32 allele homozygote) contain high numbers of both interferon gamma (IFN-gamma) and interleukin (IL)-2 producing cells, low numbers of IL-10 producing cells and no IL-4 or IL-5 producing cells when stimulated with phorbol ester and ionomycin in vitro. These results were similar to those obtained from allo-antigen specific CD4(+) T-cell lines derived from CCR5 expressing individuals An enzyme-linked immunoabsorbent assay (ELISA) confirmed that the Th1 cytokine-positive cells from the CCR5-deficient individual were able to produce equal amounts of cytokines when compared to T-cell lines from CCR5-expressing individuals These results demonstrate that CCR5-negative T cells display the same capacity of Th1 T-cell differentiation as T cells derived h-om CCR5-expressing individuals Thus, CCR5 expression is not essential for differentiation of human Th1 T cells.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 50 条
  • [41] IFN-γ and IL-12 differentially regulate CC-chemokine secretion and CCR5 expression in human T lymphocytes
    Losana, G
    Bovolenta, C
    Rigamonti, L
    Borghi, I
    Altare, F
    Jouanguy, E
    Forni, G
    Casanova, JL
    Sherry, B
    Mengozzi, M
    Trinchieri, G
    Poli, G
    Gerosa, F
    Novelli, F
    JOURNAL OF LEUKOCYTE BIOLOGY, 2002, 72 (04) : 735 - 742
  • [42] Natural proteolytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties
    Detheux, M
    Ständker, L
    Vakili, J
    Münch, J
    Forssmann, U
    Adermann, K
    Pöhlmann, S
    Vassart, G
    Kirchhoff, F
    Parmentier, M
    Forssmann, WG
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (10): : 1501 - 1508
  • [43] In vitro pharmacoregulation of CC chemokine ligand 5 and its receptor CCR5 in diffuse lung diseases
    Sekerova, V
    Subrtova, D
    Mrazek, F
    Gibejova, A
    Kolek, V
    du Bois, RM
    Petrek, M
    MEDIATORS OF INFLAMMATION, 2003, 12 (04) : 215 - 220
  • [44] Rapid determination of the Δ32 deletion in the human CC-chemokine receptor 5 (CCR5) gene without DNA extraction by LightCycler real-time polymerase chain reaction
    Nischalke, HD
    Nattermann, J
    Lichterfeld, M
    Woitas, RP
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (07) : 750 - 754
  • [45] Analysis of the CC chemokine receptor CCR5 δ32 mutation in Behcets's disease
    Yang, X
    Ahmad, T
    Gogus, F
    Wallace, G
    Madanat, W
    Kanawati, CA
    Yazici, H
    Marshall, SE
    Jewell, DP
    GUT, 2003, 52 : A55 - A55
  • [46] Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis
    Field, J
    Marshall, ACJ
    Hertzog, PJ
    Wells, TN
    Alderuccio, F
    Toh, BH
    CLINICAL IMMUNOLOGY, 2003, 109 (02) : 238 - 247
  • [47] Gating function of isoleucine-116 in TM-3 (position III: 16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5)
    Steen, A.
    Sparre-Ulrich, A. H.
    Thiele, S.
    Guo, D.
    Frimurer, T. M.
    Rosenkilde, M. M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (06) : 1566 - 1579
  • [48] Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
    Olson, WC
    Rabut, GEE
    Nagashima, KA
    Tran, DNH
    Anselma, DJ
    Monard, SP
    Segal, JP
    Thompson, DAD
    Kajumo, F
    Guo, Y
    Moore, JP
    Maddon, PJ
    Dragic, T
    JOURNAL OF VIROLOGY, 1999, 73 (05) : 4145 - 4155
  • [49] Human CC chemokine receptor 5 (CCR5) gene: Multiple transcripts with 5'-end heterogeneity and evidence for alternative promoter usage.
    Mummidi, S
    Ahuja, SS
    McDaniel, B
    Ahuja, SK
    MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 1810 - 1810
  • [50] Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease
    Annabel Rector
    Severine Vermeire
    Inge Thoelen
    Els Keyaerts
    Frank Struyf
    Robert Vlietinck
    Paul Rutgeerts
    Marc Van Ranst
    Human Genetics, 2001, 108 : 190 - 193